title: Successful rapid rituximab desensitization for hypersensitivity reactions to monoclonal antibodies in a patient with rheumatoid arthritis: a remarkable option.
authors: Cumhuriyet University, Faculty of Medicine, Chest Diseases Dept., Immunology and Allergic Diseases Subdepartment, Sivas, Turkey. oaallerji@yahoo.com
authors: O
authors: O
authors: Abadoglu
authors: K
authors: K
authors: Epozturk
authors: E
authors: E
authors: Atayik
authors: E
authors: E
authors: Kaptanoglu
mesh_terms: D000068879:Adalimumab; D000328:Adult; D017311:Amlodipine / Q000008:administration & dosage / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000276:immunology / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D058846:Antibodies, Monoclonal, Murine-Derived / Q000494:pharmacology / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000009:adverse effects* / Q000276:immunology / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000276:immunology; D001402:B-Lymphocytes / Q000187:drug effects / Q000276:immunology; D003888:Desensitization, Immunologic / Q000379:methods*; D004342:Drug Hypersensitivity / Q000209:etiology / Q000276:immunology / Q000628:therapy*; D000068800:Etanercept; D005260:Female; D006801:Humans; D006973:Hypertension / Q000139:chemically induced / Q000517:prevention & control; D007074:Immunoglobulin G / Q000009:adverse effects / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000276:immunology / Q000494:pharmacology / Q000627:therapeutic use*; D008775:Methylprednisolone / Q000008:administration & dosage / Q000627:therapeutic use; D010632:Pheniramine / Q000008:administration & dosage / Q000627:therapeutic use; D011292:Premedication; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use; D000069283:Rituximab; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D058846:Antibodies, Monoclonal, Murine-Derived; D018501:Antirheumatic Agents; D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha; D010632:Pheniramine; D017311:Amlodipine; D000069283:Rituximab; D000068879:Adalimumab; D000068800:Etanercept; D008775:Methylprednisolone